The Gut-Inflammation-Hearing Axis in Diabetic Patients Aged 30-55: Exploring Microbiome-Mediated Pathways to Auditory Complications
Hearing impairment is an underrecognized yet prevalent complication of type 2 diabetes mellitus (T2DM), but the underlying mechanisms remain poorly understood. This study investigated whether gut microbiota dysbiosis contributes to diabetic hearing loss through systemic inflammatory pathways, and evaluated the potential of microbiota-inflammation biomarkers for early risk identification.